Authors:
E Garcia, A Hayden, C Birts, E Britton, A Cowie, K Pickard, M Mellone, C Choh, M Derouet, P Duriez, F Noble, MJ White, JN Primrose, JC Strefford, M Rose-Zerilli, GJ Thomas, Y Ang, AD Sharrocks, RC Fitzgerald, TJ Underwood, OCCAMS consortium
Journal name: 
Sci Rep
Citation info: 
6:32417
Abstract: 
New biological tools are required to understand the functional significance of genetic events revealed by whole genome sequencing (WGS) studies in oesophageal adenocarcinoma (OAC). The MFD-1 cell line was isolated from a 55-year-old male with OAC without recombinant-DNA transformation. Somatic genetic variations from MFD-1, tumour, normal oesophagus, and leucocytes were analysed with SNP6. WGS was performed in tumour and leucocytes. RNAseq was performed in MFD-1, and two classic OAC cell lines FLO1 and OE33. Transposase-accessible chromatin sequencing (ATAC-seq) was performed in MFD-1, OE33, and non-neoplastic HET1A cells. Functional studies were performed. MFD-1 had a high SNP genotype concordance with matched germline/tumour. Parental tumour and MFD-1 carried four somatically acquired mutations in three recurrent mutated genes in OAC: TP53, ABCB1 and SEMA5A, not present in FLO-1 or OE33. MFD-1 displayed high expression of epithelial and glandular markers and a unique fingerprint of open chromatin. MFD-1 was tumorigenic in SCID mouse and proliferative and invasive in 3D cultures. The clinical utility of whole genome sequencing projects will be delivered using accurate model systems to develop molecular-phenotype therapeutics. We have described the first such system to arise from the oesophageal International Cancer Genome Consortium project.
DOI: 
http://doi.org/10.1038/srep32417
Research group: 
Tavaré Group
E-pub date: 
07 Sep 2016